News | September 15, 2023
Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in prevention of stroke
It´s the first trial to demonstrate the benefits of dual pathway inhibition
The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months
The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled
When used alongside rehabilitative exercise, this device may offer benefit to those who have lost function in their upper limbs due to ischemic stroke
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
